Susquehanna International Group, LLP Rapt Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$2.89 - $9.38 $5,491 - $17,822	1,900 Added 13.77%	15,700 $47,000
Q1 2024 May 07, 2024	SELL	$6.87 - $26.45 $794,172 - $3.06 Million	-115,600 Reduced 89.34%	13,800 $123,000
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $40,608 - $91,656	3,600 Added 2.86%	129,400 $3.22 Million
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $83,334 - $125,766	-5,100 Reduced 3.9%	125,800 $2.09 Million
Q2 2023 Aug 11, 2023	SELL	$16.06 - $21.61 $199,143 - $267,964	-12,400 Reduced 8.65%	130,900 $2.45 Million
Q1 2023 May 16, 2023	SELL	$17.19 - $30.8 $374,742 - $671,440	-21,800 Reduced 13.2%	143,300 $2.63 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $151,404 - $228,780	9,300 Added 5.97%	165,100 $3.27 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $1.67 Million - $2.83 Million	92,800 Added 147.3%	155,800 $3.75 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $12,312 - $28,308	-1,200 Reduced 1.87%	63,000 $1.15 Million
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $837,384 - $1.98 Million	49,200 Added 328.0%	64,200 $1.41 Million
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $651,950 - $872,950	-22,100 Reduced 59.57%	15,000 $551,000
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $316,516 - $418,382	-10,600 Reduced 22.22%	37,100 $1.15 Million
Q2 2021 Aug 11, 2021	SELL	$17.99 - $40.02 $1.57 Million - $3.5 Million	-87,400 Reduced 64.69%	47,700 $1.52 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $1.48 Million - $2.26 Million	92,500 Added 217.14%	135,100 $3 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $676,914 - $1.74 Million	42,600 New	42,600 $841,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

Vanguard Group Inc Valley Forge, PA

3.16M
Shares

$3.5 Million
0.0% of portfolio
Column Group LLC San Francisco, CA

2.68M
Shares

$2.98 Million
7.75% of portfolio
Black Rock Inc. New York, NY

2.44M
Shares

$2.71 Million
0.0% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

1.73M
Shares

$1.91 Million
0.42% of portfolio
Ponoi Management, LLC San Francisco, CA

1.6M
Shares

$1.78 Million
52.54% of portfolio

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32.9M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account